IHT Wealth Management’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-371
| Closed | -$4.95K | – | 1154 |
|
|
2024
Q2 | $4.95K | Sell |
371
-1,528
| -80% | -$20.4K | ﹤0.01% | 1022 |
|
|
2024
Q1 | $88.1K | Buy |
1,899
+12
| +0.6% | +$557 | ﹤0.01% | 976 |
|
|
2023
Q4 | $128K | Sell |
1,887
-17
| -0.9% | -$1.15K | 0.01% | 938 |
|
|
2023
Q3 | $138K | Buy |
1,904
+11
| +0.6% | +$796 | 0.01% | 906 |
|
|
2023
Q2 | $141K | Buy |
1,893
+581
| +44% | +$43.2K | 0.01% | 911 |
|
|
2023
Q1 | $69.8K | Buy |
1,312
+100
| +8% | +$5.32K | ﹤0.01% | 917 |
|
|
2022
Q4 | $82K | Sell |
1,212
-82
| -6% | -$5.55K | 0.01% | 871 |
|
|
2022
Q3 | $161K | Buy |
1,294
+132
| +11% | +$16.4K | 0.01% | 797 |
|
|
2022
Q2 | $111K | Buy |
+1,162
| New | +$111K | 0.01% | 694 |
|
|
2022
Q1 | – | Sell |
-275
| Closed | -$91K | – | 793 |
|
|
2021
Q4 | $91K | Buy |
+275
| New | +$91K | 0.01% | 780 |
|